Evidence map›Paper›PMID 26307161›Full record

ArticleThe Journal of urology2016

A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis.

Rheal A Towner, Amy B Wisniewski, Dee H Wu, Samuel B Van Gordon, Nataliya Smith, Justin C North, Rayburt McElhaney, Christopher E Aston, S Abbas Shobeiri, Bradley P Kropp and 2 more

Abstract read
In one paragraph

Article in The Journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. KRT5Stem cell research & therapy · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Assessing bladder hyper-permeability biomarkersAmerican journal of nuclear medicine and molecular imaging · 2020
    Article
  12. Recent Developments in Imaging in BPS/IC.Current bladder dysfunction reports · 2019
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Exploration of the core genes in ulcerative interstitial cystitis/bladder pain syndrome.International braz j urol : official journal of the Brazilian Society of Urology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Rheal A TownerAdvanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma; Stephenson Cancer Center, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: Rheal-Towner@omrf.org.
Amy B WisniewskiDepartment of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Dee H WuDepartment of Radiological Sciences, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Samuel B Van GordonDepartment of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Nataliya SmithAdvanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Justin C NorthDepartment of Radiological Sciences, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Rayburt McElhaneyStephenson Cancer Center, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Christopher E AstonDepartment of Pediatrics, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
S Abbas ShobeiriDepartment of Obstetrics and Gynecology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Bradley P KroppDepartment of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Beverley Greenwood-Van MeerveldDepartment of Physiology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
Robert E HurstDepartment of Urology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma; Department of Biochemistry and Molecular Biology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma; Stephenson Cancer Center, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma.
University of Oklahoma Health Sciences Center · USOU HealthOklahoma Medical Research Foundation · US

Funding

The Role of Altered Permeability in Bladder Diseases P20DK097799 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HURST, ROBERT EVAN · 2012 to 2013
$600k
BLR&D Research Career Scientist Award ApplicationIK6BX003610 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI GREENWOOD-VAN MEERVELD, BEVERLEY · 2017 to 2021
–
BLRD VA IK6 BX003610NIDDK NIH HHS P20 DK097799NIDDK NIH HHS P20DK097799
6 · The paper itself

Abstract

purposeInterstitial cystitis/bladder pain syndrome is a bladder pain disorder associated with voiding symptomatology and other systemic chronic pain disorders. Currently diagnosing interstitial cystitis/bladder pain syndrome is complicated as patients present with a wide range of symptoms, physical examination findings and clinical test responses. One hypothesis is that interstitial cystitis symptoms arise from increased bladder permeability to urine solutes. This study establishes the feasibility of using contrast enhanced magnetic resonance imaging to quantify bladder permeability in patients with interstitial cystitis. MATERIALS AND

methodsPermeability alterations in bladder urothelium were assessed by intravesical administration of the magnetic resonance imaging contrast agent Gd-DTPA (Gd-diethylenetriaminepentaacetic acid) in a small cohort of patients. Magnetic resonance imaging signal intensity in patient and control bladders was compared regionally and for entire bladders.

resultsQuantitative assessment of magnetic resonance imaging signal intensity indicated a significant increase in signal intensity in anterior bladder regions compared to posterior regions in patients with interstitial cystitis (p <0.01) and significant increases in signal intensity in anterior bladder regions (p <0.001). Kurtosis (shape of probability distribution) and skewness (measure of probability distribution asymmetry) were associated with contrast enhancement in total bladders in patients with interstitial cystitis vs controls (p <0.05). Regarding symptomatology interstitial cystitis cases differed significantly from controls on the SF-36®, PUF (Pelvic Pain and Urgency/Frequency) and ICPI (Interstitial Cystitis Problem Index) questionnaires with no overlap in the score range in each group. ICSI (Interstitial Cystitis Symptom Index) differed significantly but with a slight overlap in the range of scores.

conclusionsData suggest that contrast enhanced magnetic resonance imaging provides an objective, quantifiable measurement of bladder permeability that could be used to stratify bladder pain patients and monitor therapy.

Indexed as

AdultCase-Control StudiesContrast MediaCystitis, InterstitialFeasibility StudiesFemaleGadolinium DTPAHumansMagnetic Resonance ImagingMaleMiddle AgedPermeabilityUrinary BladderContrast MediaGadolinium DTPAcystitisinterstitialmagnetic resonance imagingpermeabilityquestionnairesurinary bladder

Identifiers

PMID26307161
PMCPMC4760854
OpenAlexW2258110775

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.